Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis

Background Numerous case-control studies have investigated the association between GSTP1 Ile105Val polymorphism and CHD risk, but the results from published studies were inconclusive. The present meta-analysis was performed to derive a more precise estimation. Methods PubMed, EMBASE, and Web of Science database searches were conducted to retrieve relevant articles. Results Ultimately, 5,451 CHD cases and 5,561 controls from 15 studies were included. Pooled analysis did not yield any statistically significant association between GSTP1 Ile105Val polymorphism and CHD risk for the overall population (Val vs. Ile: OR, 1.05; 95% CI, 0.93 to 1.18; Val/Val vs. Ile/Ile: OR, 1.09; 95% CI, 0.83 to 1.42; Val/Ile vs. Ile/Ile: OR, 1.09; 95% CI, 0.93 to 1.28; Val/Val vs. Val/Ile+Ile/Ile: OR, 1.04; 95% CI, 0.83 to 1.30; Val/Val+Val/Ile vs. Ile/Ile: OR, 1.14; 95% CI, 0.97 to 1.33). Subgroup analyses and sensitivity analyses indicated that GSTP1 Ile105Val polymorphism was still not associated with an increased risk of CHD. After excluding studies detected by Galbraith plots as major sources of heterogeneity, these relationships were still not significant. Conclusions The overall results did not reveal a major role of the GSTP1 Ile105Val polymorphism in modulating CHD risk. Well-designed studies with large sample sizes are needed to validate our findings and explore the possible gene-gene or gene-environment interactions.

[1]  X. Fang,et al.  Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study , 2021, The Journal of clinical endocrinology and metabolism.

[2]  Jiu Chen,et al.  Causal influences of neuroticism on mental health and cardiovascular disease , 2021, Human Genetics.

[3]  Jiu Chen,et al.  Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder , 2021, The Journal of clinical investigation.

[4]  Jun Zhang,et al.  Associations between maternal vitamin D status during three trimesters and cord blood 25(OH)D concentrations in newborns: a prospective Shanghai birth cohort study , 2021, European Journal of Nutrition.

[5]  Liegang Liu,et al.  An updated meta-analysis showed smoking modify the association of GSTM1 null genotype on the risk of coronary heart disease , 2021, Bioscience reports.

[6]  Z. Wang,et al.  Effects of GST null genotypes on individual susceptibility to atherosclerotic cardiovascular diseases: a meta-analysis , 2020, Free radical research.

[7]  Yunshan Cao,et al.  GST null polymorphisms may affect the risk of coronary artery disease: evidence from a meta-analysis , 2020, Thrombosis Journal.

[8]  S. Duan,et al.  LEPR hypomethylation was significantly associated with gastric cancer in males. , 2020, Experimental and molecular pathology.

[9]  Fuquan Zhang,et al.  Multi-trait analysis for genome-wide association study of five psychiatric disorders , 2020, Translational Psychiatry.

[10]  S. Duan,et al.  Genetic regulatory subnetworks and key regulating genes in rat hippocampus perturbed by prenatal malnutrition: implications for major brain disorders , 2020, Aging.

[11]  M. Dehghan Tezerjani,et al.  Association of GSTP1, GSTT1 and GSTM1 Gene Variants with Coronary Artery Disease in Iranian Population: A Case–Control Study , 2020, International journal of general medicine.

[12]  Shiwei Duan,et al.  The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review , 2020, Molecular therapy. Nucleic acids.

[13]  Manhua Liu,et al.  A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer’s disease , 2019, NeuroImage.

[14]  Mingqing Xu,et al.  Immunodeficiency Promotes Adaptive Alterations of Host Gut Microbiome: An Observational Metagenomic Study in Mice , 2019, Front. Microbiol..

[15]  S. Duan,et al.  Co-expression network analysis identified hub genes critical to triglyceride and free fatty acid metabolism as key regulators of age-related vascular dysfunction in mice , 2019, Aging.

[16]  P. Seferovic,et al.  Glutathione Transferase P1 Polymorphism Might Be a Risk Determinant in Heart Failure , 2019, Disease markers.

[17]  Jasvinder Singh Bhatti,et al.  Genetic susceptibility of glutathione S‐transferase genes (GSTM1/T1 and P1) to coronary artery disease in Asian Indians , 2018, Annals of human genetics.

[18]  Lin He,et al.  Effects of early-life malnutrition on neurodevelopment and neuropsychiatric disorders and the potential mechanisms , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  G. Gandhi,et al.  Glutathione S-transferase P1 gene polymorphisms and susceptibility to coronary artery disease in a subgroup of north Indian population , 2017, Journal of Genetics.

[20]  P. He,et al.  Glutathione S-Transferase T1 (GSTT1) Null Polymorphism, Smoking, and Their Interaction in Coronary Heart Disease: A Comprehensive Meta-Analysis. , 2017, Heart, lung & circulation.

[21]  J. Schwartz,et al.  Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study , 2016, PloS one.

[22]  W. Jia,et al.  No association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects , 2015, Leukemia & lymphoma.

[23]  B. Melegh,et al.  Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study , 2014, Molecular and Cellular Biochemistry.

[24]  F. Sung,et al.  GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan. , 2013, Gene.

[25]  D. Petrovič,et al.  Association of manganese superoxide dismutase and glutathione S-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. , 2012, Diabetes research and clinical practice.

[26]  D. Moodley,et al.  GST polymorphisms and early-onset coronary artery disease in young South African Indians. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[27]  Mingqing Xu,et al.  Genetic influences of dopamine transport gene on alcohol dependence: A pooled analysis of 13 studies with 2483 cases and 1753 controls , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  Z. Rahimi,et al.  The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran , 2011, Molecular and Cellular Biochemistry.

[29]  G. Selvam,et al.  Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. , 2011, Biochemical and biophysical research communications.

[30]  S. Agrawal,et al.  Glutathione S-Transferase Gene Polymorphism as a Susceptibility Factor for Acute Myocardial Infarction and Smoking in the North Indian Population , 2011, Cardiology.

[31]  P. Sham,et al.  A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: collaborative of 53 studies with 20,435 cases and 23,674 controls. , 2010, Atherosclerosis.

[32]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[33]  F. Hu,et al.  Quantitative Assessment of the Effect of Angiotensinogen Gene Polymorphisms on the Risk of Coronary Heart Disease , 2007, Circulation.

[34]  A. El-Sohemy,et al.  GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. , 2007, The American journal of clinical nutrition.

[35]  H. Chiou,et al.  Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. , 2007, Atherosclerosis.

[36]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[37]  D. Harrison,et al.  Role of oxidative stress in atherosclerosis. , 2003, The American journal of cardiology.

[38]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[39]  C. Wild,et al.  Glutathione S‐transferase M1 null genotype is associated with a decreased risk of myocardial infarction , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  D. Bell,et al.  Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  S. Srivastava,et al.  Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. , 1997, Archives of biochemistry and biophysics.

[42]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[43]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[44]  R F Galbraith,et al.  A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.

[45]  A. Huizink.  Progress in Neuro-Psychopharmacology & Biological Psychiatry , 2014 .

[46]  M. Andreassi,et al.  Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? , 2000, Environmental and molecular mutagenesis.

[47]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.